コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ight result in efficient treatment of social-emotional disorders.
2 ibute to the development of epilepsy-related emotional disorders.
3 nuating maladaptive memories associated with emotional disorders.
4 relations to a third group of disorders, the emotional disorders.
5 xis is a druggable target for the therapy of emotional disorders.
6 developmental disorders, and behavioral and emotional disorders.
7 potential for developing sleep therapies for emotional disorders.
8 te that subsyndromal ES precede the onset of emotional disorders.
9 escence, before manifesting as fully fledged emotional disorders.
10 ties during childhood and the development of emotional disorders.
11 gene modulation to synaptic dysfunction and emotional disorders.
12 suitable target for therapeutic treatment of emotional disorders.
13 ed with an unfavorable course of illness for emotional disorders.
14 or managing adolescent substance use-related emotional disorders.
15 ritical insights into the pathophysiology of emotional disorders.
16 may constitute an important risk factor for emotional disorders.
17 ent could improve the longitudinal course of emotional disorders.
18 cal factor that links metabolic syndrome and emotional disorders.
19 -reports and was focused on internalizing or emotional disorders.
20 target for alcohol use disorder and comorbid emotional disorders.
21 mized controlled trials and testing in other emotional disorders.
22 mans and treating anxiety or other prevalent emotional disorders.
23 sses, which are disrupted in many mental and emotional disorders.
24 t not bipolar disorder, were associated with emotional disorder and symptom scores across all ages, e
25 um disorder [ASD], schizophrenia) with youth emotional disorder and symptom scores, measured using th
26 atory processes should advance understanding emotional disorders and designing potential intervention
27 or concomitant hyperactivity/inattention and emotional disorder, and children with asthma symptoms we
29 sorders, visual disturbances, behavioral and emotional disorders, and intracranial structural injurie
30 itive disabilities, seizures, behavioral and emotional disorders, and intracranial structural injurie
31 ting Scale, Screen for Child Anxiety Related Emotional Disorders, and the severity of illness and imp
32 in many countries in recent years; trends in emotional disorders are more varied, but there is little
34 ld constitute an olfactory etiology model of emotional disorders, as exaggerated emotion-olfaction in
35 18 to 54 years of age received treatment for emotional disorders between 1990 and 1992 and 20.1 perce
36 nked to depression, schizophrenia, and other emotional disorders, but its origins and mechanisms are
37 t hippocampal inhibition of PFC may underlie emotional disorders, especially in light of reduced hipp
38 man brain evolution particularly relevant to emotional disorders: expansion of homotypical associatio
39 of disabilities was found for behavioral and emotional disorders, hearing loss, and visual disturbanc
41 ing fear conditioning has been implicated in emotional disorders in humans, the molecular mechanisms
42 s on posttraumatic stress disorder and other emotional disorders in individuals living in war and arm
43 tofrontal-related GRBMR predicted subsequent emotional disorders in late adolescence, which were gene
46 ained its association with a later course of emotional disorders in participants with subjective-only
48 rations of the reward circuit underlie major emotional disorders, including depression, which commonl
52 rsity (ELA) is a significant risk factor for emotional disorders like depression, likely due to chang
53 esponse, and its impairment is a hallmark of emotional disorders like post-traumatic stress disorder
55 en childhood maltreatment and poor course of emotional disorders over the subsequent decade were larg
56 ceptance and commitment therapy (ACT) on the emotional disorders, rumination, and life satisfaction i
57 dolescents (Screen for Child Anxiety Related Emotional Disorders: sensitivity, 64% to 74%; specificit
58 ge effect sizes in all measures of different emotional disorders showed efficacy of a single transdia
59 therapy (CBT) is an effective treatment for emotional disorders such as anxiety or depression, but t
60 oms via the Screen for Child Anxiety Related Emotional Disorders, symptoms of posttraumatic stress di
61 ed Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) is at least as efficacious as s
63 preschool-aged children with behavioral and emotional disorders warrant further examination of trend
65 9%]; adjusted RR, 2.8; 95% CI, 2.2-3.5), and emotional disorders with onset specific to childhood (12